Journals in Medicine

The Medicine portfolio strives to advance medicine by delivering superior evidence-based education, reference information and decision support tools to clinicians, trainees, and students. Specialties covered include Anesthesiology, Internal Medicine, Surgery, Radiology & Imaging, Pathology, Orthopedics, Ophthalmology, Infectious Disease, Allergy & Immunology, Pediatrics, Obstetrics & Gynecology, Hematology & Oncology, Plastic Surgery, and many more. The Medicine portfolio includes world-renowned titles such as Gray's Anatomy and Netter Atlas of Human Anatomy, Braunwald's Heart Disease, Goldman-Cecil Medicine, Osborn's Brain, Dermatology (Bolognia), Diagnostic Ultrasound (Rumack), The Harriet Lane Handbook, Fanaroff and Martin's Neonatal-Perinatal Medicine, Ferri's Clinical Advisor, Conn's Current Therapy, and more.

Books Journals

61-70 of 509 results in All results

Best Practice & Research Clinical Rheumatology

ISSN: 1521-6942
5 Year impact factor: 5.5
Impact factor: 4.5

Evidence-based updates of best clinical practice across the spectrum of musculoskeletal conditions.Best Practice & Research: Clinical Rheumatology keeps the clinician or trainee informed of the latest developments and current recommended practice in the rapidly advancing fields of musculoskeletal conditions and science.The series provides a continuous update of current clinical practice. It is a topical serial publication that covers the spectrum of musculoskeletal conditions in a 4-year cycle. Each topic-based issue contains around 200 pages of practical, evidence-based review articles, which integrate the results from the latest original research with current clinical practice and thinking to provide a continuous update.Each issue follows a problem-orientated approach that focuses on the key questions to be addressed, clearly defining what is known and not known. The review articles seek to address the clinical issues of diagnosis, treatment and patient management. Management is described in practical terms so that it can be applied to the individual patient. The serial is aimed at the physician in both practice and training.The Best Practice & Research Clinical Rheumatology series provides up-to-date and expert information and opinion by drawing on Guest Editors and authors renowned for their expertise. This ongoing review of topics makes the serial ideally suited to supporting everyday clinical practice, for training needs as well as for maintaining knowledge and competency.Volume 22 (Volume 2008):1. Connective tissue diseases M. Matucci-Cerinic & D. Furst2. Musculoskeletal science T. Pap & U. Muller-Ladner3. How to manage chronic musculoskeletal conditions - the principles P. Brooks & P. Conaghan4. Miscellanous inflammatory musculoskeletal conditions J. Sibilia & H. Zeidler5. Musculoskeletal conditions in the developing world G. Mody & R. Handa6. Imaging in musculoskeletal conditions M. Cimmino and W. GrassiVolume 23 (2009):1. Early rheumatoid arthritis2. Vasculitis3. How to do - practical procedures4. Back pain5. Systemic lupus erythematosus6. OsteoporosisVolume 24 (2010):1. Osteoarthritis2. Paediatric rheumatology3. How to manage chronic musculoskeletal conditions - a systematic approach to specific problems4. Pharmacotherapy5. Spondylo-arthropathies6. Prevention / epidemiologyThis free sample chapter is being provided to demonstrate the Journal's approach to topics across the spectrum of musculoskeletal conditions.

Best Practice & Research Clinical Rheumatology

Biochimica et Biophysica Acta: Bioenergetics

ISSN: 0005-2728
5 Year impact factor: 3.6
Impact factor: 3.4

BBA Bioenergetics covers the area of biological membranes involved in energy transfer and conversion. In particular, it focuses on the structures obtained by X-ray crystallography and other approaches, and molecular mechanisms of the components of photosynthesis, mitochondrial and bacterial respiration, oxidative phosphorylation, motility and transport. It spans applications of structural biology, molecular modeling, spectroscopy and biophysics in these systems, through bioenergetic aspects of mitochondrial biology including biomedicine aspects of energy metabolism in mitochondrial disorders, neurodegenerative diseases like Parkinson's and Alzheimer's, aging, diabetes and even cancer.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Biochimica et Biophysica Acta: Bioenergetics

Biochimica et Biophysica Acta: Molecular Basis of Disease

ISSN: 0925-4439
5 Year impact factor: 5.5
Impact factor: 4.2

BBA Molecular Basis of Disease addresses the biochemistry and molecular genetics of disease processes and models of human disease. This journal covers aspects of aging, cancer, metabolic-, neurological-, and immunological-based disease. Manuscripts focused on using animal models to elucidate biochemical and mechanistic insight in each of these conditions, are particularly encouraged. Manuscripts should emphasize the underlying mechanisms of disease pathways and provide novel contributions to the understanding and/or treatment of these disorders. Highly descriptive and method development submissions may be declined without full review.Given the complex regulation of gene expression by a vast network of miRNA's, manuscripts describing the regulation of (disease-associated) genes by single miRNAs will only be considered if they provide genuine, novel insight in a disease mechanism. Further, studies restricted to a single cell line will not be considered unless they present truly novel insights.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Biochimica et Biophysica Acta: Molecular Basis of Disease

Biochimica et Biophysica Acta: Molecular and Cell Biology of Lipids

ISSN: 1388-1981
5 Year impact factor: 4.3
Impact factor: 3.9

BBA Molecular and Cell Biology of Lipids publishes papers on original research dealing with novel aspects of lipid biology including the biosynthesis, degradation, and transport of lipids, the role of lipids and the lipidome in cells and whole organisms, and the regulation of lipid metabolism and function in normative health and disease states.Manuscripts should significantly advance the understanding of the molecular mechanisms underlying biological processes in which lipids are involved using biochemical, biophysical, cell and molecular biological, genetic, or physiological approaches. Papers detailing novel methodology should also include biochemical, molecular, or functional insight in the area of lipids. Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Biochimica et Biophysica Acta: Molecular and Cell Biology of Lipids

Biochimica et Biophysica Acta: Proteins and Proteomics

ISSN: 1570-9639
5 Year impact factor: 2.8
Impact factor: 2.5

BBA Proteins and Proteomics covers protein structure conformation and dynamics; protein folding; protein-ligand interactions; enzyme mechanisms, models and kinetics; protein physical properties and spectroscopy; and proteomics and bioinformatics analyses of protein structure, protein function, or protein regulation.The journal no longer considers manuscripts dealing with binding of compounds such as drugs or drug analogues to circulatory proteins such as serum albumin. These studies are better accommodated in journals dealing with drug design and development.Manuscripts must advance our insights into the molecular and mechanistic properties of proteins. Computational studies must generally be validated or complemented by experimental studies. Studies only consisting of computational work will not be considered unless they provide new theoretical insight that allows us to better understand or reinterpret surprising or unexpected experimental data.Comparative proteomics studies are generally not considered for review unless they provide specific insights into the structural and/or functional properties of individual proteins. Proteomics studies must also address properties of individual proteins and should as far as possible be validated by direct investigations of relevant identified proteins.Concise and comprehensive reviews of recent developments are considered for publication. However, authors are strongly advised to consult one of the Executive Editors before starting a review.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Biochimica et Biophysica Acta: Proteins and Proteomics

Biological Psychiatry

ISSN: 0006-3223
5 Year impact factor: 10.8
Impact factor: 9.6

A journal of Psychiatric Neuroscience and TherapeuticsA Publication of the Society of Biological PsychiatryBiological Psychiatry, founded in 1969, is an official journal of the Society of Biological Psychiatry and the first in the Biological Psychiatry family of journals. Companion titles include Biological Psychiatry: Cognitive Neuroscience and Neuroimaging and Biological Psychiatry: Global Open Science. The Society's purpose is to promote excellence in scientific research and education in fields that investigate the nature, causes, mechanisms and treatments of disorders of thought, emotion, and behavior. In accord with this mission, this peer-reviewed, rapid-publication, international journal publishes novel results of original basic, translational, and clinical mechanistic research that advances our understanding of psychiatric disorders and their treatment. Reviews and commentaries that focus on topics of current research and interest are also encouraged.Biological Psychiatry is one of the most selective and highly cited journals in the field of psychiatric neuroscience. The 2023 Impact Factor score for Biological Psychiatry is 9.6. It is ranked 6th out of 279 Psychiatry titles and 15th out of 309 Neurosciences titles in the Journal Citation Reports published by Clarivate Analytics. By total citations, Biological Psychiatry is ranked 2nd in Psychiatry. It is also the 7th ranked journal in Psychiatry according to Google Scholar (July 2023).Biological Psychiatry's acceptance rate is less than 10%. The average time from submission to first decision is less than 20 days, with an editorial rejection (reject without peer review) decision issued within 5 days. Accepted articles are published online, prior to copy-editing, within one week of final acceptance, with the corrected proof later replacing that version. Articles are generally published in print 6-8 months after acceptance.More information about the journal and the Society of Biological Psychiatry is available through links on this page. In addition to offering the finest reports in psychiatric neuroscience today, we hope to bring the journal's information to you in the most user-friendly and easily accessible manner. Therefore, your feedback is welcome at [email protected] responsibility is assumed by the Publisher or by the Society of Biological Psychiatry for any injury and/or damages to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. No suggested test or procedure should be carried out unless, in the reader's judgment, its risk is justified. Because of rapid advances in the medical sciences, we recommend the independent verification of diagnoses and drug dosages. Discussions, views, and recommendations as to medical procedures, choice of drugs, and drug dosages are the responsibility of the authors.

Biological Psychology

ISSN: 0301-0511
5 Year impact factor: 3
Impact factor: 2.7

Biological Psychology publishes original scientific papers on neural, endocrine, immune, and other physiological aspects of psychological states and processes. Such aspects include assessments by biochemistry, electrophysiology, and neuroimaging during psychological experiments as well as biologically induced changes in psychological function. Psychological investigations based on biological theories are also of interest. All aspects of psychological functioning, including psychopathology, are germane.The Journal is focused on work with human individuals, but may consider work with animals, if conceptually related to issues in human biological psychology. The Journal welcomes work that spans disciplines and methods and recruits an editorial team that is especially suited for handling such manuscripts. Empirical reports are the core of the Journal, but methodological and theoretical reports relevant to biological psychology are encouraged (see list of article types for more information). Finally, the Journal regularly publishes special issues on selected topics within its scope.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Biomaterials

ISSN: 0142-9612
5 Year impact factor: 13.1
Impact factor: 12.8

Biomaterials is an international journal covering the science and clinical application of biomaterials. A biomaterial is now defined as a substance that has been engineered to take a form which, alone or as part of a complex system, is used to direct, by control of interactions with components of living systems, the course of any therapeutic or diagnostic procedure. It is the aim of the journal to provide a peer-reviewed forum for the publication of original papers and authoritative review and opinion papers dealing with the most important issues facing the use of biomaterials in clinical practice. The scope of the journal covers the wide range of physical, biological and chemical sciences that underpin the design of biomaterials and the clinical disciplines in which they are used. These sciences include polymer synthesis and characterization, drug and gene vector design, the biology of the host response, immunology and toxicology and self assembly at the nanoscale. Clinical applications include the therapies of medical technology and regenerative medicine in all clinical disciplines, and diagnostic systems that reply on innovative contrast and sensing agents. The journal is relevant to areas such as cancer diagnosis and therapy, implantable devices, drug delivery systems, gene vectors, bionanotechnology and tissue engineering.Click here for New Editorial Instructions.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support CenterBiomaterials is the flagship title in Elsevier's biomaterials science portfolio; it sits alongside Materials Today Bio, Biomaterials Advances and Biomaterials and Biosystems . As part of the broader Materials Today family, Biomaterials offers authors rigorous peer review, rapid decisions, and high visibility. We look forward to receiving your submissions!

Blood

ISSN: 0006-4971
5 Year impact factor: 19.2
Impact factor: 21

Blood, the flagship journal of the American Society of Hematology, published online and in print, provides an international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations in hematology. Acceptance of manuscripts is based on the originality and importance of the observations or investigations, the quality of the work and validity of the evidence, the clarity of presentation, and the relevance to our readership and field. All articles are expected to be concise, well-organized and clearly written. Authors submit a manuscript with the understanding that the manuscript (or its essential substance) has not been published other than as an abstract in any language or format and is not currently submitted elsewhere for print or electronic publication.Primary research articles will be published under the following scientific categories: Clinical Trials and Observations; Gene Therapy; Hematopoiesis and Stem Cells; Immunobiology and Immunotherapy; Myeloid Neoplasia; Lymphoid Neoplasia; Phagocytes, Granulocytes and Myelopoiesis; Platelets and Thrombopoiesis; Red Cells, Iron and Erythropoiesis; Thrombosis and Hemostasis; Transfusion Medicine; Transplantation; and Vascular Biology. Papers can be listed under more than one category as appropriate. Authors are invited to submit a presubmission inquiry if they are uncertain whether their work falls within the general scope of the journal.Blood has formulated more precise scopes for immunobiology and immunotherapy, vascular biology, HIV/HTLV, and clinical trial submissions. The journal is very interested in submissions as reflected in the definitions linked below.Immunobiology and Immunotherapy scopeVascular Biology scopeHIV/HTLV scopeClinical Trials scopeBlood welcomes submission of manuscripts reporting on clinical trials whether phase 1, 2, 3 or 4. Reports should include a full description of the study design, patient population, methodology and conduct, and statistical plan.Immunobiology and Immunotherapy encompass a wide spectrum of research, but Blood can accommodate only papers that have clear and important implications for hematology. Preference is given to papers focusing on human immunobiology, immunotherapy, and immune pharmacology approaches in the human setting and those with significant implications for understanding of normal or malignant hematologic processes. Papers on tumor immunology, tumor vaccines and cancer immunotherapy development may be appropriate if the target cells or antigens are relevant to hematologic malignancies, but generally Blood cannot accommodate tumor immunology papers focusing solely on non-hematologic tumor types.Papers investigating autoimmunity and utilizing non-hematologic models are not within the scope of Blood.Vascular biology papers that focus primarily on atherosclerosis are outside the scope of Blood and instead should be considered for alternative journals.Papers felt to be outside the scope of Blood will be returned to the author without full peer review.

Blood Cells, Molecules and Diseases

ISSN: 1079-9796
5 Year impact factor: 2.2
Impact factor: 2.1

BCMD is interested in contributions in basic, translational and clinical research focusing on the biology of blood cells and the pathophysiology of blood disorders, with a specific interest in non-malignant conditions.We will consider studies on hematological malignancies when secondary to inherited or acquired bone marrow failure or disorders of the immune system.Research Areas include:Erythropoiesis, Erythrocyte Biology, Hemoglobin and its disordersMyelopoiesis, myeloid cells and disorders of the myeloid lineage (incl. myeloproliferative disorders)Megakaryopoiesis and platelet disordersHemostasis & Thrombosis and disorders of coagulationTransfusion medicine and the study of therapeutic blood products (including novel biotechnologies related to transfusion products)Bone marrow failure (severe aplastic anemia, myelodysplasia, etc.)Immunodeficiency and dysregulation of the immune systemAuto-immune disorders relating to blood

Related subjects

Aids and hiv

Allergy and clinical immunology

Anatomy

Anesthesiology

Basic medical science

Biochemistry

Cancer

Cardiology and cardiovascular medicine

Chemotherapy

Clinical medicine

Clinical neurology

Colon and rectal surgery

Critical care

Dermatology

Diagnostic imaging

Diet therapy

Emergency medicine

Endocrinology and metabolism

Epidemiology

Family practice

Forensic medicine

Gastroenterology and hepatology

General medicine

Genetics

Geriatrics

Health care delivery

Health information management

Health policy

Health risk assessment

Hematology

Histology

Holistic medicine

Infectious diseases

Internal medicine

Laboratory medicine

Medicaid and medicare

Medical biotechnology

Medical caregiving

Medical education and training

Medical ethics

Medical informatics

Medical neuroscience

Medical practice management and reimbursement

Medical research

Microbiology

Nephrology

Neurosurgery

Obstetrics and gynecology

Oncology

Ophthalmology

Optometry

Orthopedics and biomechanics

Osteopathy

Otorhinolaryngology

Pain medicine

Pathology

Pediatrics

Perinatology and neonatology

Pharmacology

Physical medicine and rehabilitation

Plastic surgery

Preventive medicine

Psychiatry

Public environmental and occupational health

Pulmonary and respiratory medicine

Radiology nuclear medicine and medical imaging

Reproductive medicine

Review and reference

Rheumatology

Sports medicine

Substance abuse

Surgery

Thoracic surgery

Ultrasonography

Urology

Vascular surgery

Life sciences

Physical sciences & Engineering

Social sciences & Humanities

Health